Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

- PMLiVE

J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma

Darzalex treatment regimen reduced risk of death by 32% after nearly five years follow-up

- PMLiVE

US trial data shows Novavax’s COVID-19 vaccine is 90% effective

The jab was also found to provide protection against variants of concern and variants of interest

- PMLiVE

AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial

AZD7442 is based on antibodies isolated from two patients who had recovered from COVID-19

- PMLiVE

Diversity and inclusion in clinical trials

By Nuala Murphy

- PMLiVE

Novartis’ iptacopan scores positive results in rare blood disorder PNH

Oral therapy led to transfusion-independent improvements in haemoglobin levels for the majority of patients

- PMLiVE

BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial

Results presented at EHA2021 virtual congress showed an improved overall response rate for Brukinsa of 78.3%

Roche Basel Switzerland

Roche reveals four-year follow-up data for Venclyxto in CLL at EHA2021

At 30 months post-treatment, 26.9% of Venclyxto-treated patients had undetectable minimal residual disease

- PMLiVE

Building the hospital of the future

Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience.

Avalere Health

- PMLiVE

bluebird bio presents new data for beti-cel in beta thalassemia at EHA2021

Gene therapy shows sustained efficacy across paediatric and adult patient populations

- PMLiVE

Fair representation in research matters to the sector and to society

By Annette Jack

- PMLiVE

Anna Korving joins Resonant Group as non-executive director

Resonant Group has also appointed Korving as an advisor to the board

- PMLiVE

Resonant Group appoints Stephen Marchant as chief development officer

Previously, Marchant held the role of group client strategy officer at Omnicom’s Healthcare Consultancy Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links